<p>Mutational signatures derived from whole genome sequencing have potential prognostic significance.  Identification of high grade serous ovarian cancer patients with deficiency in homologous recombination repair pathways could identify a subset of patients that would benefit from homologous recombination deficiency-specific treatments independent of identification of a pathological BRCA1/2 gene mutation.  Clinical protocols rely on a pathologist's assessment of formalin-fixed paraffin-embedded (FFPE) tissues, and thus FFPE tissue samples are readily available.  However, the bulk of mutational signature analyses have been performed on fresh frozen tissues.  In this study, we aimed to assess the reliability of whole genome sequencing, variant calling, and mutational signature analysis from FFPE tissue samples.</p>

Single Cell Genome Variation Induced by Mutational Processes in Cancer - HGSOC Trios Study

Demographics (1)

Other (9)